U.S. Aerospace & Defense Stock News

NYSE:MCK
NYSE:MCKHealthcare

McKesson’s ASCO 2026 Data Highlights Evolving Role In Community Oncology

McKesson (NYSE:MCK) supported new research presented at ASCO 2026 by The US Oncology Network. The study found that advanced practice provider led consult models can significantly improve patient access in community oncology. Findings also indicate higher physician capacity when these consult models are used in real world clinic settings. This is a fresh data point on how McKesson is involved in reshaping care delivery for cancer patients. For investors tracking McKesson as more than a...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

A Look At Playtika Holding’s Valuation As Bingo Blitz Adds Where’s Waldo Collaboration

What the Bingo Blitz and Where's Waldo? tie-up means for Playtika Holding (PLTK) Playtika Holding (PLTK) is drawing fresh attention after its Bingo Blitz title introduced a Where's Waldo? themed in-game takeover, created with Universal Products & Experiences, adding branded rooms while keeping the core bingo format intact. For investors, this type of collaboration can matter because it may influence user engagement, player spending patterns, and the overall visibility of Playtika's portfolio,...
NYSE:UNF
NYSE:UNFCommercial Services

Is UniFirst (UNF) Stock Fairly Priced After The Essential Series Restroom Hygiene Launch

Essential Series launch and why it matters for UniFirst stock UniFirst (UNF) has introduced its Essential Series restroom hygiene program, pairing eight coordinated dispensers with a managed service model that targets operational efficiency, predictable billing, and reduced maintenance demands for facility operators. See our latest analysis for UniFirst. UniFirst's Essential Series launch lands at a time when the stock is trading at $265.42, with a 30 day share price return of 3.76% and a...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Is Up 7.1% After Blue Origin Launch Setback Spurs Execution-Risk Downgrade

Earlier this month, AST SpaceMobile was hit by the fallout from a Blue Origin New Glenn rocket explosion, which damaged the launch pad and raised fresh questions about the timing of future BlueBird satellite launches, prompting a downgrade from Deutsche Bank on execution risk grounds. The incident highlights how AST SpaceMobile’s ambitious plan to scale a direct-to-phone satellite network depends not only on technology and demand, but also on reliable access to multiple launch...
NasdaqGS:KHC
NasdaqGS:KHCFood

Assessing Kraft Heinz (KHC) Valuation After Annual Results Reveal Revenue And Net Loss

Why Kraft Heinz (KHC) is back on investor radar Kraft Heinz (KHC) is drawing fresh attention after its annual figures showed revenue of US$24.99b alongside a net loss of US$5.76b, prompting investors to reassess the stock’s value profile and recent share performance. See our latest analysis for Kraft Heinz. Recent trading reflects this mixed picture, with a 7.09% 1 month share price return contrasted against a 1 year total shareholder return that is down 5.86%. This suggests some short term...
NasdaqGM:OLLI
NasdaqGM:OLLIMultiline Retail

Does Softer Q2 Comp Sales Guidance Change The Bull Case For Ollie’s Bargain Outlet (OLLI)?

Ollie's Bargain Outlet recently signaled that comparable sales growth for its second quarter is likely to be low, while analysts and investors looked ahead to the now-past April 2026 quarter earnings report, which was expected to show higher revenue and earnings versus a year earlier. This combination of cautious management commentary and tempered expectations for an earnings surprise has sharpened attention on how resilient Ollie’s closeout-driven, value-focused model may be if same-store...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

NVIDIA Deepens Taiwan AI Hub With US$150b Bet And Investor Questions

NVIDIA (NasdaqGS:NVDA) is set to headline Taipei's Computex conference with a major keynote. CEO Jensen Huang plans to raise annual investment in Taiwan to as much as US$150b. The company is breaking ground on a new Taiwan headquarters and expanding its local presence. The moves highlight Taiwan's role in NVIDIA's AI hardware supply chain and ecosystem plans. NVIDIA, traded as NasdaqGS:NVDA, sits at the center of the global AI hardware build out, supplying GPUs and related platforms that...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

A Look At BrightSpring Health Services (BTSG) Valuation After Upward Earnings Revisions And Strong Home Based Care Demand

BrightSpring Health Services (BTSG) is back in focus after analysts raised earnings estimates, citing better cash flow trends and steady demand for its home-based care services across pharmacy and provider offerings. See our latest analysis for BrightSpring Health Services. The recent upward revisions in earnings estimates come alongside strong share price momentum, with a 28.1% 30 day share price return and a 60.6% year to date share price return. The 1 year total shareholder return is...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks NATO Alliance And AI Security Push Reshape Cyber Spend

Palo Alto Networks has entered a new partnership with NATO, deepening its role in global cyber defense collaboration. The company is focusing on accelerating enterprise AI adoption, tying its platform more closely to AI driven security use cases. These moves come as AI related software stocks rally and new integrations highlight demand for AI native security tools. Palo Alto Networks, NasdaqGS:PANW, operates at the intersection of cybersecurity and AI, with the stock recently closing at...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Did Warby Parker's AI-Powered Intelligent Eyewear Collaboration Just Shift Warby Parker's (WRBY) Investment Narrative?

Earlier in May 2026, Warby Parker Inc. unveiled its first Intelligent Eyewear frame, created with Google and Samsung to integrate AI-powered assistance into everyday glasses and planned a broader optical and sun collection launch for this fall. This move marks Warby Parker’s entry into wearable technology by combining its design and fit data with Google’s Gemini and Samsung’s Android XR platforms to extend how glasses function in daily life. We’ll now examine how this collaboration around...
NYSE:AFG
NYSE:AFGInsurance

A Look At American Financial Group (AFG) Valuation As Share Price Momentum Cools

Recent share performance and context American Financial Group (AFG) stock has seen mixed recent returns, with the price down 1.7% on the day and 5.0% over the past week, while roughly flat over the past month. See our latest analysis for American Financial Group. At a share price of $129.8, American Financial Group has seen recent share price momentum cool, with the share price down over the week and year to date, even as the 1 year and 5 year total shareholder returns of 10.3% and 56.1%...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Assessing FuboTV (FUBO) Valuation After Steep Share Price Weakness And Discounted Sales Multiple

Recent performance snapshot FuboTV (FUBO) has been on many watchlists after a challenging stretch for the stock, including declines over the past month, past 3 months, year to date, and over the past year. At a recent close of US$10.09 and a market value of about US$1.1b, the company sits at an interesting point for investors who are assessing how its live TV streaming focus and current financial profile fit their risk tolerance. See our latest analysis for FuboTV. Short term momentum has...
NasdaqGS:MAR
NasdaqGS:MARHospitality

Is It Too Late To Consider Marriott International (MAR) After A 44% One Year Run?

Wondering whether Marriott International at around US$375.60 is still reasonable value after a strong run, or if you might be paying too much for the stock. The share price sits at US$375.60 after returns of 1.7% over the past week, 6.1% over the past month, 19.8% year to date and 43.6% over the last year. These moves naturally raise questions about growth potential and changing risk perceptions. Recent news coverage has focused on Marriott International's position as a large global hotel...
NYSE:THG
NYSE:THGInsurance

A Look At Hanover Insurance Group (THG) Valuation After Recent Choppy Share Price Moves

Recent performance snapshot Hanover Insurance Group (THG) has drawn investor attention after recent share price moves, with the stock last closing at $186.20 and posting mixed short term returns alongside longer term total returns that reflect compounding. See our latest analysis for Hanover Insurance Group. Recent trading has been choppy, with the share price down 4.6% over the past week but still up 4.9% over the past month. Multi year total shareholder returns of 50% to 74% point to a...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) Quarterly Profit Drop Tests Bullish Margin Narratives

UiPath (PATH) has reported Q1 2027 revenue of US$418.4 million and basic EPS of US$0.04, setting a clear marker for how the automation specialist is currently converting top line into profit. The company has seen quarterly revenue move from US$356.6 million in Q1 2026 to US$418.4 million in Q1 2027, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.04. This points to a materially different earnings profile compared with the same period last year. For investors, the key...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

Is Hut 8 (HUT) Using Louisiana Water Upgrades to Cement Its AI Infrastructure Pivot?

Hut 8 Corp. recently agreed to invest about US$16,000,000 to expand West Feliciana Parish’s water system as part of its River Bend AI data center campus, including a new well and roughly eight miles of water main, with the upgraded infrastructure to be handed over to the parish at no cost to taxpayers. This privately funded infrastructure build-out, alongside Hut 8’s large-scale AI data center projects and rising institutional interest, underscores the company’s shift from pure Bitcoin...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Is Up 15.4% After Positive Lifyorli Phase 3 Ovarian Cancer Survival Data – Has The Bull Case Changed?

Earlier this week, Corcept Therapeutics reported Phase 3 ROSELLA data showing that Lifyorli combined with nab-paclitaxel reduced the risk of death for patients with platinum-resistant ovarian cancer compared with chemotherapy alone, reinforcing the clinical profile of its recently approved therapy. The new overall survival results, presented at ASCO 2026, also support Lifyorli’s inclusion as a preferred regimen in national ovarian cancer treatment guidelines, underscoring its potential...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

A Look At Beam Therapeutics (BEAM) Valuation After Updated BEAM 302 Trial Data And Accelerated Approval Plans

Why BEAM-302’s latest data matters for Beam Therapeutics stock Beam Therapeutics (BEAM) has drawn fresh attention after presenting updated Phase 1/2 BEAM-302 data for alpha-1 antitrypsin deficiency at the ATS 2026 conference, highlighting safety outcomes, durability signals and reduced neutrophil elastase activity. See our latest analysis for Beam Therapeutics. The updated BEAM-302 data has arrived alongside strong momentum in the stock, with a 7 day share price return of 14.98% and a year to...
NYSE:SWK
NYSE:SWKMachinery

A Look At Stanley Black & Decker (SWK) Valuation After Recent Share Price Momentum

Recent performance snapshot Stanley Black & Decker (SWK) has drawn fresh attention after recent share price moves, with the stock near US$79.42 and showing mixed returns over the past week, month, past 3 months, and year to date. See our latest analysis for Stanley Black & Decker. Set against a 1-year total shareholder return of 27.2%, the recent 3.9% 7-day share price return and 4.7% 1-month share price return suggest momentum has picked up again after a softer 90-day patch, even though the...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

HealthEquity (HQY) Net Margin Jump To 17.3% Tests Bullish Profitability Narrative

HealthEquity’s Q1 2027 earnings snapshot HealthEquity (HQY) opened its Q1 2027 report with total revenue of US$354.6 million and basic EPS of US$0.82, supported by net income of US$69.4 million. Over the past six quarters, revenue has moved from US$311.8 million in Q4 2025 to US$354.6 million in Q1 2027, while quarterly basic EPS has ranged from US$0.30 to US$0.82, and trailing twelve month EPS has reached US$2.70 on revenue of about US$1.3 billion. With trailing net profit margins reported...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla FSD Scrutiny Puts Robotaxi Promise And Valuation In Focus

Regulatory filings in Texas show Tesla (NasdaqGS:TSLA) has 42 vehicles registered for autonomous operations, far fewer than leading competitor Waymo, drawing fresh attention to its robotaxi rollout. Whistleblower accounts from former Tesla data labelers point to safety gaps in Full Self-Driving, including issues around school buses, emergency vehicles, and pedestrians. These developments feed into ongoing regulatory scrutiny and raise questions about Tesla's ability to scale its robotaxi...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

Assessing WaFd (WAFD) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals

Why WaFd (WAFD) is on investors’ radar today WaFd (WAFD) has drawn fresh attention after recent share price moves, with the stock last closing at US$35.56. Investors are weighing that level against the bank’s reported revenue and earnings profile. See our latest analysis for WaFd. WaFd’s recent pullback of less than 1% on the day comes after a stronger run, including a 14.12% 90 day share price return and a 29.38% 1 year total shareholder return, suggesting momentum has been building over...
NYSE:SHAK
NYSE:SHAKHospitality

Is Shake Shack (SHAK) Starting To Look Attractive After Its 50% One-Year Share Price Fall?

Wondering whether Shake Shack at US$64.31 per share is starting to look like a bargain or still carries too much optimism in the price? This article walks through what that current tag really implies about value. The stock has risen 2.5% over the past week, but is down 36.1% over the last 30 days and has fallen 23.0% year to date and 50.5% over the past year, which can change how investors think about both upside and risk. Recent coverage has focused on how this sharp pullback has reset...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Is It Too Late To Consider Synopsys (SNPS) After Recent Share Price Pullback?

Wondering if Synopsys at around US$475 a share still offers value, or if the easy money has already been made? This article focuses squarely on what the current price might imply. The stock has been choppy recently, with the share price down 9.4% over the past week, 1.2% over the past month, and 1.0% year to date, while the 1 year return sits at 2.5% and the 5 year return at 85.9%. Recent coverage of Synopsys has centered on its role in software for chip design and automation tools, along...